✦ LIBER ✦

281 Transforming growth factor β (TGF-β) is a potent modulator of human IgE synthesis

✍ Scribed by WU, C; BRINKMANN, V; HEUSSER, C; COX, D; DELESPESSE, G

Book ID: 119060465
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 142 KB
Volume: 87
Category: Article
ISSN: 1097-6825
DOI: 10.1016/0091-6749(91)91564-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type β transforming growth factor is a p

Type β transforming growth factor is a potent modulator of differentiated adrenocortical cell functions

✍ J.J. Feige; C. Cochet; E.M. Chambaz 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 443 KB

Transforming Growth Factor-β Is a Potent

Transforming Growth Factor-β Is a Potent Negative Regulator of Human Lymphocytes

✍ JOHN H. KEHRL; ALAN TAYLOR; SEONG-JIN KIM; ANTHONY S. FAUCI 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

TGF-β is a potent inhibitor of hepatocyt

TGF-β is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts

✍ GOHDA, E; MATSUNAGA, T; KATAOKA, H; YAMAMOTO, I 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 490 KB

The Conventional Transforming Growth Fac

The Conventional Transforming Growth Factor-β (TGF-β) Receptor Type I Is Not Required for TGF-β1 Signaling in a Human Prostate Cancer Cell Line, LNCaP

✍ Isaac Yi Kim; David J. Zelner; Chung Lee 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 557 KB

Modulation of complement biosynthesis in

Modulation of complement biosynthesis in human monocytes by transforming growth factor-beta (TGF-β) and lipopolysaccharide

✍ A.K.M. Høgån; K. Hestdal; T.G. Abrahamsen 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Transforming growth factor β1 (TGF-β1) i

Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors

✍ S. Jozan; M. Guerrin; P. Mazars; M. Dutaur; B. Monsarrat; F. Cheutin; R. Bugat; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 957 KB

## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited